Omega Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.221; its P/E ratio is -0.97; Omega Therapeutics is scheduled to report earnings on March 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 759.00K	$ 516.00K	$ 734.00K	$ 595.00K	$ 476.00K
Gross Profit	$ 378.00K	$ 104.00K	$ -205.00K	-	-
EBIT	$ -30.20M	$ -26.38M	$ -32.06M	$ -25.98M	$ -25.86M
EBITDA	$ 0.00	$ -25.02M	$ -27.84M	$ -25.59M	$ -25.45M
Net Income Common Stockholders	$ -29.69M	$ -25.28M	$ -30.83M	$ -25.80M	$ -25.91M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 112.98M	$ 136.79M	$ 124.68M	$ 148.35M	$ 173.66M
Total Assets	$ 229.05M	$ 156.31M	$ 141.84M	$ 170.06M	$ 193.05M
Total Debt	$ 118.63M	$ 22.23M	$ 22.53M	$ 22.89M	$ 23.38M
Net Debt	$ 5.65M	$ -114.55M	$ -102.14M	$ -125.46M	$ -150.28M
Total Liabilities	$ 133.11M	$ 33.31M	$ 145.95M	$ 36.41M	$ 35.66M
Stockholders Equity	$ 95.92M	$ 123.00M	$ 105.97M	$ 133.65M	$ 157.38M
Cash Flow	-
Free Cash Flow	-	$ -28.08M	$ -24.51M	$ -25.16M	$ -26.70M
Operating Cash Flow	-	$ -28.08M	$ -24.22M	$ -24.84M	$ -26.09M
Investing Cash Flow	-	$ 22.05M	$ 17.65M	$ 10.59M	$ 11.27M
Financing Cash Flow	-	$ 39.99M	$ 586.00K	$ 4.00K	$ 35.00K

Currency in USD

Omega Therapeutics Earnings and Revenue History

Income Statement >

Omega Therapeutics Debt to Assets

Balance Sheet >

Omega Therapeutics Cash Flow

Cash Flow >

Omega Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing